Used in the synthesis of biologically active compounds, particularly in pharmaceutical research targeting central nervous system disorders. Its chiral cyclopropanamine structure makes it valuable as an intermediate in developing selective enzyme inhibitors and receptor modulators. The trifluoromethylpyridine moiety enhances metabolic stability and binding affinity, which is beneficial in optimizing drug candidates for improved pharmacokinetics. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its rigid framework and stereochemical properties.